
	Where results make sense

Topic: Cipla

Related Topics

Lists of companies

Ranbaxy Laboratories Limited

Biovail

Shire Pharmaceuticals

National Thermal Power Corporation

Archies Limited

Birla Corporation Limited

AstraZeneca plc

Pharmaceutical

ALZA Corporation

ONGC

Hindustan Lever Limited

Arvind Mills

Tata Consultancy Services

La Crosse

In the News (Sun 6 Dec 09)

Northern Trust

Marvin Harrison

Peter Chernin

Gary Locke

Match Play

Penelope Cruz

Mickey Rourke

AR Rahman

Danny Boyle

Hugh Jackman

	Cipla Pharmaceuticals
		Cipla Statement on WHO Prequalification of 3TC and AZT.
		November 20, 2000 Letter from GlaxoWellcome to CIPLA regarding CIPLA's export of Duovir to Uganda.
		Letter from Dr. Hamied, Director of Cipla, to J.V.R. Prasada Rao, in which he confirms that child formulations are included in the Cipla offer.
	www.cptech.org /ip/health/cipla (916 words)

	Cipla -- Facts, Info, and Encyclopedia article (Site not responding. Last check: 2007-11-06)
		Cipla ignores the (An official document granting a right or privilege) patents on these drugs, but no Indian law is broken in the process.
		With Cipla drugs, the cost of treating an AIDS patient has been reduced from $12,000 to $300 per year, still out of reach for most Indians.
		Cipla produces an all-in-one pill called Lamivudine which contains all three substances, something difficult elsewhere because the three patents are held by different companies.
	www.absoluteastronomy.com /encyclopedia/c/ci/cipla.htm (103 words)

	The Telegraph - Calcutta : Nation (Site not responding. Last check: 2007-11-06)
		Cipla confirmed the move today after the patents were uncovered by people familiar with the AIDS situation and attending the 15th International AIDS Conference in Bangkok.
		Cipla argues its scientists found the way to put them together to produce the combination pill, which needs to be taken only twice a day.
		Cipla’s entry into the patent arena may offer it commercial protection from rivals looking to copy its know-how in combining the three original medicines.
	www.telegraphindia.com /1040713/asp/nation/story_3488871.asp (499 words)

	Cipla develops non-CFC inhaler
		Cipla's wholetime director Amar Lulla told The Financial Express that the company's CFC-free inhaler, branded Asthalin HFA, will be ready for a domestic launch shortly, even as the company is working concurrently on export registrations in major markets, including Europe and South Africa.
		Cipla officials, however, say even this price level could be lowered "substantially" if the existing import duty levy of approximately 42 per cent is eased.
		Cipla's successful development of its CFC-free inhaler comes even as the company has sought patentprotection for its new dry powder asthma inhalation device, Rotahaler (a novel inhalation device used with rotacap formulations), in Australia, Europe and South Africa.
	www.expressindia.com /fe/daily/19990614/fco14069.html (538 words)

	Cipla offers cheap AIDS drugs \| survivreausida.net (Site not responding. Last check: 2007-11-06)
		Cipla has offered to pay the patent-holders a royalty on its sales if it is allowed to sell its low-priced generic version of the drugs in Third World countries, mostly in Africa, which are in the grip of an AIDS epidemic.
		Cipla’s offer is time-bound, it has asked for a response by January 25, 2001, "given the urgency of the public health crisis".
		Cipla also says that the commercial manufacture of active pharmaceutical durg ingredients like pioglitazone, topotecan, abacavir, alosetron, apraclonidine, linezolid, among others are on the anvil in the near future.
	www.survivreausida.net /a4680 (4633 words)

	AIDS relief at a fraction of the U.S. price / Indian drugmaker sidesteps patents with U.N. blessing
		Cipla executives say the only thing holding back production is the political will on the part of wealthy nations to pay for it.
		Cipla executives insist that the pills meet the WHO standard and that the problem lies with paperwork at an independent firm that conducted bioequivalence studies.
		Cipla pledged to repeat the studies by the end of this month.
	www.sfgate.com /cgi-bin/article.cgi?file=/c/a/2004/07/07/MNG4D7HMJ11.DTL&type=printable (845 words)

	[Ip-health] Bill Haddad/CIPLA statement on WHO prequalification
		Cipla was unable to respond last night because the Hudson Institute began to solicit media after corporate Cipla in Mumbai, India had closed for the day.
		In a routine and intimate follow-up inquiry by WHO and Cipla, it was discovered that the necessary back-up documentation at the CRO did not meet accepted standards.
		Cipla conducts approximately thirty or more bioequivalence studies a year in CROs in India and elsewhere in the world.
	lists.essential.org /pipermail/ip-health/2004-June/006566.html (508 words)

	Cipla Ltd.
		Cipla is pioneer in anti-AIDS segment and has obtained orders from Nigerian and Cameroon Governments for the supply of its anti-AIDS cocktail drugs.
		Cipla has entered into the FMCG segment with the launch of shaving cream, toothpaste, baby powder and cold cream.
		Cipla is pioneer in the anti-AIDS segment offering the full range of drugs required for the AIDS therapy.
	www.valuenotes.com /krc/jul3101.asp?ArtCd=27636 (1340 words)

	AEGiS-WSJ: Drug Industry, AIDS Community Is Jolted by Cipla AIDS-Drug Offer
		But Cipla's offer is still expected to shake up negotiations taking place between some African countries and the group of five big pharmaceutical companies.
		What is especially significant about Cipla's action is that its price appears to be even lower than a sharply-discounted price a group of drug makers is offering to nations in Africa.
		Cipla is offering to sell just three of the roughly 10 drugs commonly combined to form the so-called AIDS cocktail therapy.
	www.aegis.com /news/wsj/2001/WJ010207.html (1266 words)

	Cipla's gift to Clinton Foundation
		Indian pharmaceutical giant Cipla will give AIDS medicines at half the normal prices to former US President Bill Clinton's Foundation, which has decided to provide $10 million this year for treatment of 10,000 children in 10 developing nations.
		Cipla has reached an agreement with the William J Clinton Presidential Foundation to supply pediatric AIDS medicines at half the cost, which will help extend treatment to twice the number of children.
		Cipla has agreed to sell its syrups and child-sized pills at half of its normal price as the foundation is placing large orders, said Ira Magaziner, chairman of AIDS Initiative for the Foundation.
	inhome.rediff.com /money/2005/apr/12cipla.htm (289 words)

	The Hindu : Cipla offers low cost AIDS drug
		Cipla has offered `Medicines sans Frontiers' (MsF) or `Doctors Without Borders' the AIDS therapy drugs for $350 per patient per annum as against a normal cost of the AIDS cocktail of $10,000- 15,000 per patient per annum.
		Cipla has a huge capacity for the manufacture of the drugs and, according to Mr.
		Cipla has among the best research & development facilities in the country and is also into chiral chemistry (the process of producing a superior version of an existing drug).
	www.hinduonnet.com /2001/02/15/stories/06150005.htm (583 words)

	[Pharm-policy] Hindu on CIPLA offer
		Cipla is supplying the drugs to Medicines Sans Frontiers (MSF) (Doctors without Borders) who will be distributing the drugs in Africa and Southeast Asia.
		A joint press statement issued by MSF and Cipla says that governments of developing countries can immediately take advantage of the offer made by the Mumbai-based Cipla for its triple-combination anti-retroviral drugs for $600 per patient per year by contacting the company directly.
		Cipla co-operates with drug regulatory authorities to provide all necessary documentation for registration as required in individual countries.'' said the joint press release.
	lists.essential.org /pipermail/pharm-policy/2001-February/000733.html (606 words)

	Cipla gets Rs 1.5 cr royalty from global majors
		Aotuokang Cipla (in which the Indian company holds a 55 per cent stake) will manufacture a range of antibiotics, life-saving infusions and anti-cancer drugs and is located in the Jinhua Economic Development Zone in central Zheijiang province.
		Cipla is also in talks with a multinational company to undertake developmental work in the area of formulations.
		In 1995-96, Cipla's investment in R&D as a per cent of turnover was 2.8 per cent (or Rs 10.11 crore) and Lulla said that this would go up to 4-5 per cent over the next few years.
	www.expressindia.com /fe/daily/19970528/14855483.html (344 words)

	The Hindu Business Line : Cipla: Buy
		Admittedly, Cipla's business model of having tie-ups with various generic players in the US such as Ivax, Watson and Eon, may not be as lucrative as entering the market directly; however, it does save the company substantially on costs (both filing and legal), which can be quite significant.
		Cipla has commenced production at its facilities at Baddi in Himachal Pradesh and the full tax benefits of the operation are likely to manifest in the quarters ahead.
		Cipla is contesting a case involving the pricing regulator (the National Pharmaceutical Pricing Authority) on grounds of having charged prices in excess of those laid down by the regulator.
	www.thehindubusinessline.com /iw/2005/07/31/stories/2005073100591000.htm (600 words)

	Boston.com / Your Life / Health & Fitness / Diseases & Treatments / Two drugs off WHO's list of HIV medicines (Site not responding. Last check: 2007-11-06)
		The versions of the drugs -- known as lamivudine (3TC) and zidovudine (AZT) -- are made by Cipla, an Indian firm that specializes in providing generic drugs to developing countries.
		WHO did not find any problems during its original inspection of the company, but another laboratory carrying out what are known as bioequivalency tests for Cipla could not provide the required documentation.
		Cipla has told WHO that it is contracting a new laboratory and conducting new bioequivalency tests.
	www.boston.com /yourlife/health/diseases/articles/2004/06/16/two_drugs_off_whos_list_of_hiv_medicines (606 words)

	Meeting with Cipla
		One of these companies, Cipla, has announced its offer to work with MSF to bring HIV-related medicines at affordable prices to the people who need them in developing countries.
		A meeting took place today at WHO between staff from Cipla, WHO, UNAIDS, the European Commission and MSF, in order for the UN organizations to get clarification on a range of issues relating to Cipla's recent offer to make reduced price triple combination therapy available in developing countries.
		The information supplied by Cipla today will be evaluated to see how Cipla's offer can be included in the information that the UN makes available to interested governments and nongovernmental organizations through its Accelerating Access Initiative.
	www.aegis.com /news/unaids/2001/UN010301.html (537 words)

	Israeli drug giant eyes Cipla, Dr Reddy's
		It is that Teva, the world number two in generics from Israel, is getting ready to emerge from the shadows in India with a big-bang acquisition of a large local drug maker.
		Cipla has large-scale bulk drug and finished medicine facilities that make everything from antibiotics to AIDS medicines for scores of markets.
		Cipla is also the fourth largest drug maker in the world by volume.
	inhome.rediff.com /money/2005/may/13teva.htm (1990 words)

	AEI - Short Publications (Site not responding. Last check: 2007-11-06)
		Cipla responded that the de-listing was a mere clerical error.
		Cipla, however, is now engaged in new tests, according to a WHO official.
		Cipla and other makers of knockoff AIDS drugs demonstrate "through proper clinical trials" that their drugs are just as safe and effective as patented drugs and true generics in use in developed countries.
	www.aei.org /publications/pubID.20896,filter.all/pub_detail.asp (1174 words)

	rediff.com: Cipla, Ranbaxy expand marketing deal (Site not responding. Last check: 2007-11-06)
		Cipla shares were up Rs 15.85 at Rs 841 on Monday afternoon, while Ranbaxy shares were down Rs 21.25 at Rs 631.50.
		Under the deal, Ranbaxy and Cipla market the same products under their own brand names with a view to increasing the size of the market for the molecules involved.
		Cipla's sales of its corresponding brands Carloc, Atorlip and Cefoprox were Rs 54 million in the same period.
	www.rediff.com /money/2000/oct/09cipla.htm (378 words)

	Chemical & Engineering News: Latest News - Cipla Readies Avian Flu Drug
		Cipla, an Indian producer of generic drugs, is preparing to become an alternative producer of oseltamivir phosphate, an antiviral drug better known by the brand name Tamiflu.
		But Cipla has neither produced the drug in large quantities nor is able to predict whether its price will be much lower than Roche’s.
		Cipla plans to offer Tamiflu in the Indian market and in 49 less-developed countries where the company already sells AIDS treatments, Hamied says.
	pubs.acs.org /cen/news/83/i43/8343cipla.html (436 words)

	TopSearch10 - Search Results - ciprofloxacin cipla (Site not responding. Last check: 2007-11-06)
		Find Ciprofloxacin Cipla any many other great deals at MonsterMarketplace!
		Save up to 80% on your medical costs.
		Shop and compare best prices on Ciprofloxacin Cipla and millions of other products.
	ciprofloxacin-cipla.tbl.sytes.net (61 words)

	Equitymaster.com : Cipla: 1QFY03 net up 36%
		Cipla has reported an encouraging 35% growth in net profits and a corresponding rise in sales for 1QFY03.
		Further, Cipla has tied up with several US generic companies for supply of bulk drugs, which have 'first-to-file status' ('first-to-file status' ensures marketing exclusivity for generic companies).
		Though the opening up of the African market for anti-AIDS market has provided a big export opportunity for Cipla, the profitability from same is unascertainable at this point of time.
	www.equitymaster.com /detail.asp?date=7/24/2002&story=3 (299 words)

	The Hindu : Cipla launches new AIDS drug
		Cipla today launched a triple drug cocktail for HIV/AIDS under the brand name Triomune.
		Cipla is also making available a paediatric formulation of nevirapine called Nevimune Suspension.
		Cipla first launched Zidovir, an anti-retroviral in 1993 in the domestic market.
	www.hinduonnet.com /2001/08/07/stories/06070007.htm (285 words)

	Companies & Industry
		Cipla has ended GlaxoSmithKline’s long reign as the leading player in the Indian pharmaceutical market, according to research agency ORG’s statistics.
		Cipla’s market share for the 12-month period ended May 2004 was 5.53 per cent, against Glaxo’s 5.52 per cent, as per the report.
		It is known to be an aggressive player in the domestic market, and exports medicines to several countries from manufacturing facilities in India.
	www.business-standard.com /common/storypage.php?hpFlag=Y&chklogin=N&autono=162066&leftnm=lmnu1&leftindx=1&lselect=0 (338 words)

	Indian drug company offers cheap AIDS drugs (Site not responding. Last check: 2007-11-06)
		The decision by Bombay-based Cipla Ltd. could revolutionize the treatment of HIV patients in developing countries, where the virus is most rampant.
		Cipla will sell the three-drug, anti-retroviral cocktail to Doctors Without Borders, a Paris-based medical aid agency, at the discounted price as long as they agree to distribute the drug for free, said Dr. Yusuf Hamied, Cipla's chairman.
		The group was studying the proposal and was to meet with Cipla representatives in Bombay next week, she said from Paris.
	www.usatoday.com /news/world/2001-02-07-aidscocktail.htm (884 words)

	Cipla, RLL working on anti-AIDS drugs - Sify.com
		Cipla and Ranbaxy, which have played a significant role in the generic AIDS drugs segment - albeit for adults - are now developing chemically similar paediatric dosage forms of anti-AIDS medicines, executives with both companies confirmed to Business Line.
		Cipla is working on developing a dosage of triomune that can be given to children and babies, said Amar Lulla, Joint Managing Director.
		About three years ago, Cipla had played a significant role in driving anti-AIDS drugs prices down in Africa by offering generic versions of the drugs at one-thirtieth of the original cost.
	sify.com /finance/equity/fullstory.php?id=13637163 (495 words)

	SC ruling in drug overpricing hits Cipla- The Economic Times (Site not responding. Last check: 2007-11-06)
		According to government estimates, Cipla owes the public Rs 100 crore as half the overcharged amount.
		Cipla is one of the leading companies involved in the case.
		Cipla, later obtained a stay on recovery proceedings from the Allahabad HC, against which the NPPA again approached the Supreme Court last July.
	economictimes.indiatimes.com /articleshow/987719.cms (376 words)

	domain-B : Indian business : companies : Cipla : index (Site not responding. Last check: 2007-11-06)
		Cipla eyes formulations exports to attain Rs 17-billion turnover
		Cipla to launch non-CFC salbutamol inhaler in August
		Cipla eyes US generic market, in talks for alliance
	www.domainb.com /companies/companies_c/cipla (89 words)

Try your search on: Qwika (all wikis)